Cargando…
P317: ANTI-LEUKEMIA ACTIVITY OF CD70-DIRECTED IMMUNOTHERAPY IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Autores principales: | Sun, Qian, Zabrocki, Piotr, Seyfried, Felix, de Haard, Hans, Kronnie, Geertruyte, Debatin, Klaus-Michael, Hinrich Meyer, Lüder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428390/ http://dx.doi.org/10.1097/01.HS9.0000968180.63394.07 |
Ejemplares similares
-
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Manzano-Muñoz, Albert, et al.
Publicado: (2021) -
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
por: Demir, Salih, et al.
Publicado: (2020) -
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model
por: Hasan, Md. Nabiul, et al.
Publicado: (2014) -
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical ALL xenograft model in vivo
por: Schirmer, Melanie, et al.
Publicado: (2014) -
Characterization and identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
por: Trentin, Luca, et al.
Publicado: (2014)